Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2016Q3 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2016Q2 $ vs. 2016Q2
ARDELYX, INC. ON STOCK 1,057,257 $13,680,000 0.88% New +$13,680,000
Blueprint Medicines Corp ON STOCK 460,024 $13,662,000 0.88% New +$13,662,000
Depomed Inc ON STOCK 535,000 $13,370,000 0.86% New +$13,370,000
ALDER BIOPHARMACEUTICALS INC ON STOCK 391,280 $12,822,000 0.83% New +$12,822,000
FOAMIX PHARMACEUTICALS LTD ON STOCK 1,373,284 $12,717,000 0.82% New +$12,717,000
CYTOMX THERAPEUTICS, INC PREFERRED STOCK 742,021 $11,634,000 0.75% New +$11,634,000
Minerva Neurosciences, Inc. ON STOCK 810,537 $11,440,000 0.74% New +$11,440,000
Zynerba Pharmaceuticals, Inc. ON STOCK 868,897 $11,339,000 0.73% New +$11,339,000
ELI LILLY & Co ON STOCK 331,610 $11,215,000 0.72% New +$11,215,000
Clearside Biomedical, Inc. ON STOCK 634,801 $11,013,000 0.71% New +$11,013,000
Aclaris Therapeutics, Inc. ON STOCK 430,000 $11,012,000 0.71% New +$11,012,000
Evolent Health, Inc. ON STOCK 428,284 $10,544,000 0.68% New +$10,544,000
VBI Vaccines Inc/BC ON STOCK 3,058,433 $10,490,000 0.68% New +$10,490,000
MyoKardia, Inc. ON STOCK 634,894 $10,374,000 0.67% New +$10,374,000
uniQure N.V. ON STOCK 1,312,836 $10,043,000 0.65% New +$10,043,000
VERTEX PHARMACEUTICALS INC / MA ON STOCK 107,000 $9,331,000 0.60% New +$9,331,000
ANI PHARMACEUTICALS INC NOTE 3.000% 7,500,000 $9,279,000 0.60% New +$9,279,000
Cidara Therapeutics, Inc. ON STOCK 773,369 $8,855,000 0.57% New +$8,855,000
FIVE PRIME THERAPEUTICS, INC. ON STOCK 166,509 $8,740,000 0.56% New +$8,740,000
Forward Pharma A/S DEPOSITORY RECEIPT 404,472 $8,494,000 0.55% New +$8,494,000
Pfenex Inc. ON STOCK 939,930 $8,412,000 0.54% New +$8,412,000
ABIOMED INC ON STOCK 63,290 $8,138,000 0.53% New +$8,138,000
ABEONA THERAPEUTICS INC. ON STOCK 1,336,050 $8,016,000 0.52% New +$8,016,000
AVEXIS INC ON STOCK 190,000 $7,830,000 0.51% New +$7,830,000
EyePoint Pharmaceuticals, Inc. ON STOCK 2,552,431 $7,683,000 0.50% New +$7,683,000